CIK 0001267565 · Large accelerated filer
COLLEGIUM PHARMACEUTICAL, INC
Sign in to watch- Ticker
- COLL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- Phone
- 781-713-3699
- Business address
- 100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA, 02072
- Former names
- COLLEGIUM PHARMACEUTICAL INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-12 | Kuhlmann Shirley R. EVP and General Counsel | Shares withheld for taxes | −10,610 | $33.70 | $358K | 164,409 |
| 2024-02-12 | Ciaffoni Joseph President and CEO | Grant or award | +119,000 | 394,000 | ||
| 2024-02-12 | Ciaffoni Joseph President and CEO | Grant or award | +179,734 | 573,734 | ||
| 2024-02-12 | Ciaffoni Joseph President and CEO | Shares withheld for taxes | −47,445 | $33.70 | $1.6M | 526,289 |
| 2024-02-12 | Ciaffoni Joseph President and CEO | Shares withheld for taxes | −81,422 | $33.70 | $2.7M | 444,867 |
| 2024-01-16 | Dreyer Scott EVP & Chief Commercial Officer | Sale 10b5-1 | −23,560 | $32.28 | $761K | 111,322 |
| 2023-12-21 | Ciaffoni Joseph President and CEO | Option exercise 10b5-1 | +4,357 | $21.34 | $93K | 279,357 |
| 2023-12-21 | Ciaffoni Joseph President and CEO | Sale 10b5-1 | −4,357 | $30.38 | $132K | 275,000 |
| 2023-12-21 | Ciaffoni Joseph President and CEO | Option exercise · Stock Option (Right to Purchase) 10b5-1 | −4,357 | 16,875 | ||
| 2023-12-20 | Ciaffoni Joseph President and CEO | Option exercise 10b5-1 | +26,454 | $21.34 | $565K | 301,454 |
| 2023-12-20 | Ciaffoni Joseph President and CEO | Sale 10b5-1 | −26,454 | $30.40 | $804K | 275,000 |
| 2023-12-20 | Ciaffoni Joseph President and CEO | Option exercise · Stock Option (Right to Purchase) 10b5-1 | −26,454 | 21,232 | ||
| 2023-12-19 | Ciaffoni Joseph President and CEO | Option exercise 10b5-1 | +14,516 | $21.34 | $310K | 289,516 |
| 2023-12-19 | Ciaffoni Joseph President and CEO | Sale 10b5-1 | −14,516 | $30.03 | $436K | 275,000 |
| 2023-12-19 | Ciaffoni Joseph President and CEO | Option exercise · Stock Option (Right to Purchase) 10b5-1 | −14,516 | 47,686 | ||
| 2023-12-18 | Ciaffoni Joseph President and CEO | Option exercise 10b5-1 | +27,798 | $21.34 | $593K | 302,798 |
| 2023-12-18 | Ciaffoni Joseph President and CEO | Sale 10b5-1 | −27,798 | $30.04 | $835K | 275,000 |
| 2023-12-18 | Ciaffoni Joseph President and CEO | Option exercise · Stock Option (Right to Purchase) 10b5-1 | −27,798 | 62,202 | ||
| 2023-11-27 | Kuhlmann Shirley R. EVP and General Counsel | Option exercise 10b5-1 | +25,600 | $15.90 | $407K | 145,118 |
| 2023-11-27 | Kuhlmann Shirley R. EVP and General Counsel | Sale 10b5-1 | −25,600 | $25.78 | $660K | 119,518 |
Page 9 of 24 · 462 trades